Skip to content

Laser therapy for onychomycosis in patients with diabetes at risk for diabetic foot complications A randomized, double blind controlled trial.

Laser therapy for onychomycosis in patients with diabetes at risk for diabetic foot complications A randomized, double blind controlled trial. - LASER-1

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41598
Enrollment
64
Registered
2013-11-25
Start date
2015-03-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fungal nail infection onychomycosis

Interventions

One group receives treatment with a local laser treatment (Diode-pumped solid-state laser) from a podiatrist and the other group receives treatment according to a control procedure. The laser proced
1064 nm, spot size 3 mm, 20 J /cm2, 5 Hz, power 10 W, pulse duration 132 millisecond.

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: known diabetes (type 1 or 2) over 18 years old clinically suspicion with microbiologic confirmation of onychomycosis at risk for diabetic foot ulcers defined by a Simm*s score 1 or 2 the nail has to be involved for at least 25% .

Exclusion criteria

Exclusion criteria: patients without microbiologic confirmation of fungal nail infection patients with diabetic foot ulcers or foot ulcer in the medical history patients who used systemic or topical antifungal agents during the preceding 3 months patients with insufficient knowledge of the Dutch language to understand the requirements of the study patients who use immunosuppressive medication will also be excluded. patients suffering from psoriasis with nail involvement, lichen planus, or other abnormalities that could result in clinically abnormal toenails will be excluded. patients with an ankle brachial index

Design outcomes

Primary

MeasureTime frame
• Complete cure of the target nail

Secondary

MeasureTime frame
• Microbiological cure of the target nail • Complete clinical cure of the target nail • Markedly improved target nail • Complete clinical cure of all clinically infected toes • Nail severity index below 6 (in patients with a score >6 at study entry) of the target toe • Health related quality of life • Surface with healthy target nail / all clinically infected toes • Patients free of hyperkeratosis

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)